Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
Ruiz-Argüelles
Guillermo J
GJ
Centro de Hematología y Medicina Interna de Puebla, 8B Sur 3710, 72530 Puebla, PUE, Mexico. gruiz1@puebla.megared.net.mx
Gómez-Almaguer
David
D
López-Martínez
Briceida
B
Cantú-Rodríguez
Olga G
OG
Jaime-Pérez
José C
JC
González-Llano
Oscar
O
D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D016044:Fusion Proteins, bcr-abl / Q000097:blood; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000191:economics; D018183:Transplantation Chimera; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000191:economics; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl